B. Kosel

Pharmacokinetics of indinavir in HIV-positive pregnant women.

F. Aweeka, M. Homma, K. Beckerman, 2000, AIDS.

Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: Searching for exposure‐response relationships

J. Church, L. Sheiner, F. Aweeka, 2003, Clinical pharmacology and therapeutics.

Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women

S. Hayashi, F. Aweeka, M. Homma, 2003, AIDS.

The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir

N. Benowitz, S. Shade, J. Hilton, 2002, AIDS.

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047

C. Fichtenbaum, T. Blaschke, J. Aberg, 2002, AIDS.

Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection

N. Benowitz, M. Schambelan, T. Elbeik, 2003, Annals of Internal Medicine.

Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.

Michael S Saag, Michael J Mugavero, Heidi M Crane, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical interaction between efavirenz and phenytoin.

S. Dhanireddy, C. Spak, B. Kosel, 2008, AIDS.

Drug interactions of antiretroviral agents.

F. Aweeka, B. Kosel, 2000, AIDS clinical review.